Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “SULFANILAMIDE”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 91 records · Page 5Linked to original sources

Quaternary ammonium sulfanilamide: a membrane-impermeant carbonic anhydrase inhibitor.

A novel carbonic anhydrase (CA) inhibitor, quaternary ammonium sulfanilamide (QAS), was tested for potency as a CA inhibitor and for its ability to be excluded from permeating biological membranes. Inhibitor titration plots of QAS vs. pure bovine CA II and CA from the gills of the blue crab, Callinectes sapidus, yielded Ki values of approximately 15 microM; thus QAS is a relatively weak but effective CA inhibitor. Permeability of the QAS was directly tested by two independent methods. The inhibitor was excluded from human erythrocytes incubated in 5 mM QAS for 24 h as determined using an 18O-labeled mass spectrometer CA assay for intact cells. Also QAS injected into the hemolymph of C. sapidus (1 or 10 mM) did not cross the basal membrane of the gill. The compound was cleared from the hemolymph by 96 h after injection, and at no time during that period could the QAS be detected in homogenates of gill tissue. Total branchial CA activity was only slightly reduced following the QAS injection. These data indicate that QAS is a CA inhibitor to which biological membranes are impermeable and that can be used in vivo or in vitro in the study of membrane-associated CA.

Animals↗

Enhancement of sulfanilamide N4-hydroxylase activity in kidney and liver microsomes of rats by pretreatment with 3-methylcholanthrene type-polychlorinated biphenyl.

N4-Hydroxylation of sulfanilamide was studied with kidney and liver microsomes of rats by means of high performance liquid chromatography. In kidney microsomes, both contents of cytochrome P-450 (448) and activity of N4-hydroxylase were markedly increased by pretreatment with 3,4,5,3',4'-pentachlorobiphenyl (PenCB) (about 4 times), although neither one was increased by 3-methylcholanthrene (3-MC) and phenobarbital (PB) pretreatments. In liver microsomes, on the other hand, both N4-hydroxylase activity and cytochrome P-450 (448) contents were increased by either PenCB or 3-MC pretreatment, whereas by PB pretreatment, N4-hydroxylase activity was not changed although cytochrome P-450 contents was increased 2-fold.

Animals↗

[Conformations and interatomic distances in polymorphs of sulfanilamide].

By CNDO (Complete Neglect of Differential Overlap) molecular orbital method, interatomic distances and XYZ cartesian corrdinates were calculated in five polymorphs (monohydrated, alpha, two beta, and gamma) of sulfanilamide. Interatomic distances thus obtained are very close to those originally presented by Bells & Roblin and support the mechanism of action postulated long algo for sulfa drugs as being competitive antagonism with p-aminobenzoic acid.

4-Aminobenzoic Acid↗

[Long-term results of therapy of patients with diabetes mellitus and secondary resistance to sulfanilamides].

Three groups of patients suffering from diabetes mellitus with secondary sulfanilamide resistance (SS) were observed. The first group was given sugar-lowering drugs since the disease was diagnosed, the second group -- insulin plus hypoglycemic drugs, the third group -- insulin injections. The patients were followed up for 6-10 years, from the time of SS development -- 4.6 years. Stable compensation of diabetes mellitus was better achieved with combined therapy including sugar-lowering drugs per os and insulin, a dose of insulin being less by 22 units than in patients on insulin only. Progression of diabetic angiopathies was also less noticeable in the second group on combined therapy. The most unfavorable course of diabetic angiopathies and their progression were observed in the first group on sugar-lowering drugs per os.

Adult↗

[Sensitivity of Pseudomonas mallei to sulfanilamide combinations in vitro].

It was shown that 9 strains of P. mallei were sensitive to sulfanilamides and their combinations with trimethoprim: sulfamonomethoxine + trimethoprim (2.5:1), sulfamethoxazole + trimethoprim (5:1) and sulfazin + trimethoprim (2.5:1 and 5:1). In regard to multiple lowering of the minimum bactericidal concentration of both drugs the combinations of sulfazin with trimethoprim (5:1 or 2.5:1) and sulfamethoxazole with trimethoprim (5:1) or biseptol proved to be the most active. The activity of the sulfamonomethoxine combination with trimethoprim (sulfate) was lower.

Drug Combinations↗

[Relation between molecular structure and the antibacterial activity of N4-substituted sulfanilamides].

With the aim of establishing a correlation between chemical structure and biologic activity of series N, N'-replaced carbamide and thiocarbamide derivatives, containing sulfanilamide group their antibacterial activity has been studied. The microbiologic screening towards eight kinds of gram-positive and gram-negative microorganisms showed that the substitutes in N and N' in the carbamide or thiocarbamide structure influence the force of the effect as well as the kind of microorganisms in which that effect is exhibited. Ascertained was that together with the increase of the number of carbon atoms is strengthen the antibacterial activity (highest in C4) as the derivatives containing aryl radical show higher activity than those containing alkyl radical. The bringing of halogenic atoms in the molecule of the synthesized derivatives increases considerably the antibacterial activity which is expressed mainly in the combinations containing Cl-atom in m-position of the benzene nucleus.

Bacteria↗

Metabolism of sulfanilamide and related drugs in isolated rat and rabbit liver cells.

Parenchymal and nonparenchymal cells were isolated from rat and rabbit liver by perfusion with collagenase. Pure parenchymal cells were obtained by centrifugation at low speed and nonparenchymal cells were purified by treatment with pronase. Suspensions of parenchymal cells from rat liver metabolized sulfamethazine, sulfanilamide, and p-aminobenzoic acid at rates of 39.0, 75.8, and 173.2 pmol/min/10(6) cells, respectively, but did not metabolize sulfadiazine. Rabbit liver parenchymal cells gave somewhat higher activities and also metabolized sulfadiazine. Nonparenchymal cells from both rat and rabbit liver failed to metabolize any of the compounds.

4-Aminobenzoic Acid↗

[Furazan sulfanilamides].

Synthesis and antibacterial activity against Escherichia coli of a series of furazan sulfanilamides are reported. A structural activity relationship for these derivatives is also briefly discussed.

Anti-Bacterial Agents↗

[Acetylation of sulfanilamide substances in toxic lesions of the liver].

In experimental toxic hepatitis induced by injection of CCl4 into rats, the rat blood and urine content of acetylated sulfamonomethoxine diminishes, the acetylation of sulfamonomethoxine and norsulfazole in an isolated stomach of the rat reduces, and acetylation of sulfamonomethoxine is inhibited by rat liver and small intestine homogenates. This confirms that different types of pathology (infectious and non-infectious) provoke the same line of changes, namely the reduction of acetylation of sulfanilamide substances in the body. CCl1 decreases sulfamonomethoxine acetylation by a mixture of the mitochondria and microsomes of the rat liver, i. e. eliminates the synergistic effect characteristic for intact rats. The reduction of acetylation recorded at different levels of the organization of the living systems--bodily, organ and subcellular ones--is accounted for by the lowering of the acetylcoenzyme A content in the tissues. One of the reasons for reduction of acetylation during the CCl4-induced liver injury lies in the impairment in the liver cells of the interaction between the mitochondria and endoplasmic reticulum.

Absorption↗

[Sulfanilamide binding and distribution in the liver cells of rats].

Experiments on white noninbred rats were made to study the binding by isolated organoids and distribution in liver cells of etazole, norsulfazole, sulfamonomethoxine and sulfalene. The latter drug was found to be absorbed by organoids to the greatest degree. Drug complexes with organoids were discovered to be capable of dissociating with a partial release of unbound drug. Intracellular distribution of sulfanilamides is marked by their accumulation primarily by the nuclei and to a lesser degree by the mitochondria and microsomes.

Animals↗

[Distribution of sulfanilamides and penicillins in the blood and organs of rats after their combined administration].

The use of benzylpenicillin and ampicillin in combination with sulfalen or sulfadimethoxine increased the levels of the penicillins and sulfalen in some organs and tissues of rats. This was accompanied by a rise in the concentration gradients of the drugs. It is concluded that the combined use of the penicillins and sulfanilamides determines their increased penetration from the blood into other organs and tissues of the host.

Administration, Oral↗

Formation of a transplacental mutagen, 1,3-Di(4-sulfamoylphenyl)triazene, from sodium nitrite and sulfanilamide in human gastric juice and in the stomachs of hamsters.

1,3-Di(4-sulfamoylphenyl)triazene was abundantly produced by incubation of sulfanilamide (SA) and NaNO2 in human gastric juice. This reaction also occurred in acetate buffer (pH approximately 4) at 37 degrees C as well as in hydrochloric acid (pH < 1) under ice cooling, with the product forming in almost the same amount. This phenomenon indicated the broad range of conditions under which the reaction occurs. The intragastric formation of this triazene was also demonstrated in Syrian golden hamsters by the concurrent administration of SA and NaNO2. Mutants resistant to 8-azaguanine were induced in a dose-dependent manner in the culture of embryo cells that were derived from pregnant hamsters 24 hours after ip injection of this triazene.

Animals↗

[Activity of di-N-hydroxyquinoxaline and depot-sulfanilamide derivatives in experimental NAG infection].

In experiments in vitro dioxidineeee was highly effective as regards all the test cultures of NAG-vibrios. The MTC ranged within 1 to 62 micrograms/ml. Bactericidal action of the drug became manifest at concentrations from 4 to 250 micrograms/ml. The derivatives of di-N-oxide quinoxaline, dioxidin and quinoxidine exerted a chemotherapeutic effect and sterilizing action in experimental NAG-infection. The action of the drugs was potentiated upon combined use with lysozyme. As far as depo-sulfanilamides are concerned, sulfalenee was little active, while sulfamonomethoxine ineffective in experimental NAG-infection.

Animals↗

Determination of the onset of crystallization of N1-2-(thiazolyl)sulfanilamide (sulfathiazole) by UV-Vis and calorimetry using an automated reaction platform; subsequent characterization of polymorphic forms using dispersive Raman spectroscopy.

This work describes the use of UV/visible spectroscopy and calorimetry to follow the onset of crystallization of a commercially available compound, N(1)-2-(thiazolyl)sulfanilamide (sulfathiazole), during crystallization reactions performed using an automated reaction platform. Sulfathiazole has been the subject of numerous publications through which considerable confusion about the morphic form is apparent. This work does not attempt to investigate exhaustively the polymorph issue, but rather to exploit the use of the HEL auto-MATE for monitoring the onset of crystal formation. Real-time calorimetry and UV-Vis spectroscopy are compared as tools for determining the onset of crystallization. Subsequently, differential scanning calorimetry, dispersive Raman, and infrared spectroscopy analysis serve to identify the crystal forms generated by the HEL auto-MATE. A solvent-anti-solvent matrix and several bench-top crystallization experiments were performed to supplement the investigation in terms of generating the desired polymorphs.

Ammonia↗